Biocartis Group NV: Results of the annual general meeting held on 13 May 2016
(Thomson Reuters ONE) -
PRESS RELEASE: REGULATED INFORMATION
Results of the ANNUAL GENERAL MEETING held on 13 may 2016
Mechelen, Belgium, 13 May 2016 - Biocartis Group NV ('Biocartis'), an innovative
molecular diagnostics company (Euronext Brussels: BCART), held its annual
general shareholders' meeting ('AGM') in Mechelen today. The shareholders
approved all items on the agenda of the AGM, including the appointment of Mrs.
Hilde Eylenbosch as new independent director, as well as the re-appointment as
director of Messrs. Roald Borré and Rudi Mariën (acting through Gengest BVBA).
----- END ----
For more information, please contact:
Renate Degrave, Corporate Communications & Investor Relations
rdegrave(at)biocartis.com
+32 15 631 729
About Biocartis
Biocartis (Euronext Brussels: BCART) is an innovative molecular diagnostics
(MDx) company providing next generation diagnostic solutions aimed at improving
clinical practice for the benefit of patients, clinicians, payers and industry.
Biocartis' proprietary MDx Idylla(TM) platform is a fully automated sample-to-
result, real-time PCR (Polymerase Chain Reaction) system that offers accurate,
highly reliable molecular information from virtually any biological sample in
virtually any setting. Biocartis launched the Idylla(TM) platform in September
2014. Biocartis is developing and marketing a rapidly expanding test menu
addressing key unmet clinical needs in oncology and infectious diseases. These
areas represent respectively the fastest growing and largest segments of the MDx
market worldwide. Today, Biocartis has four oncology tests and one test for
infectious diseases on the market. More information: www.biocartis.com. Follow
us on Twitter: (at)Biocartis_.
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biocartis Group NV via GlobeNewswire
[HUG#2012577]
Unternehmensinformation / Kurzprofil:
Datum: 13.05.2016 - 15:52 Uhr
Sprache: Deutsch
News-ID 471037
Anzahl Zeichen: 2565
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 230 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biocartis Group NV: Results of the annual general meeting held on 13 May 2016"
steht unter der journalistisch-redaktionellen Verantwortung von
Biocartis Group NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
